Vaxxas, a clinical-stage biotechnology company commercializing a novel high-density microarray patch (HD-MAP) vaccination platform, today announced that CEPI, the Coalition for Epidemic Preparedness ...
The University of Queensland's BASE facility – within the Australian Institute for Bioengineering and Nanotechnology (AIBN) – and Brisbane-based biotechnology company Vaxxas have been announced as ...
We're expecting Apple to release a new iPhone SE model this year, likely in March. As such, I'd advise against picking up the iPhone SE (2022) until this newer model's existence is confirmed (or ...